High purity LDK378 Ceritinib 1032900-25-6

Payment Type:	L/C,T/T,Paypal
Incoterm:	FOB,CIF
Min. Order:	10 Gram
Delivery Time:	5 Days

Contact Now

Basic Info

Model No.: 1032900-25-6

Additional Info

Packaging: 1G

Productivity: 1 kg/month

Brand: cy

Transportation: Ocean,Land,Air

Place of Origin: China

Supply Ability: 1 kg

Certificate: ISO 9001, gmp

Port: QINGDAO,SHANGHAI

Product Description

Ceritinib is a new ALK gene inhibitor (ALKi) developed by Novartis Pharmaceuticals; its commercial name is Zykadia, and its previous code was LDK378. It was approved by the FDA for sale on April 29, 2014, and it is used to treat anaplastic lymphoma kinase (ALK) positive transfer of crizotinib (CRZ) progress or intolerance of non-small cell lung cancer (NSCLC).

Product name	Ceritinib
CAS	1032900-25-6
MF	C28H36ClN5O3S
MW	558.13
EINECS	811-457-8
Application	API Raw Material

English Name	CAS
Dasatinib	302962-49-8
Dasatinib monohydrate	863127-77-9
Nilotinib	641571-10-0
Nilotinib hydrochloride monohydrate	923288-90-8
Ponatinib	943319-70-8
Sorafenib	284461-73-0
Sorafenib tosylate	475207-59-1
Pomalidomide	19171-19-8
Lapatinib	231277-92-2
Lapatinib ditosylate	388082-78-8
Nitisinone	104206-65-7
Tofacitinib citrate	540737-29-9
Pazopanib	444731-52-6
Pazopanib hydrochloride	635702-64-6
Osimertinib AZD9291	1421373-65-0
Osimertinib Mesylate(AZD9291)	1421373-66-1
Trametinib	871700-17-3
3-cycloproppyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione	871700-24-2
3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)-2,4(1H,3H )-pyrimidinedione	871700-22-0
N-(3-{[3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7 -trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl]amino}ph enyl)acetamide	871700-25-3
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl 4-methylbenzenesulfonate	871700-32-2
Bosentan	147536-97-8
Lenalidomide	191732-72-6
3-Methyl-6-nitro-1H-indazole	6494-19-5
2,3-dimethyl-6-nitroindazole	444731-73-1
2,3-dimethyl-2H-indazol-6-amine	444731-72-0
2,3-dimethylindazol-6-amine HCl	635702-60-2
N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine	444731-74-2
2,3-dimethyl-2H-indazol-6-amine hydrochloride	635702-60-2
Masitinib	790299-79-5
2-bromo-1-pyridin-3-ylethanone hydrobromide	17694-68-7
N-(2-Methyl-5-nitrophenyl)-4-(3-pyridinyl)-2-thiazolamine	1048007-94-8
N-(2-methyl-5-nitrophenyl)-4-pyridin-3-yl-1,3-thiazol-2-amine	1048007-94-8
Sorafenib tosylate	475207-59-1
Erlotinib hydrochloride	183319-69-9
Gefitinib	184475-35-2
INCB28060	1029712-80-8
Cabozantinib L-Malate	1140909-48-3
LDK378	1032900-25-6
Ceritinib dihydrochloride	1380575-43-8
alectinib	1256580-46-7
Lapatinib ditosylate	388082-78-8
Crizotinib	877399-52-5
Sunitinib Malate	341031-54-7
Venetoclax	1257044-40-8
Selumetinib	606143-52-6
AZD3759	1626387-80-1
EAI045	1942114-09-1
Baricitinib	1187594-09-7
Dovitinib	915769-50-5
Regorafenib	755037-03-7
Nintedanib	656247-17-5
Nintedanib Ethanesulfonate Salt	656247-18-6
Nintedanib	656247-17-5
Lenvatinib	417716-92-8
lenvatinib mesylate	857890-39-2
PCI-32765	936563-96-1
Abemaciclib	1231929-97-7
AP26113	1197958-12-5
Aptinib	811803-05-1
Anlotinib	1058156-90-3
AZD1775	955365-80-7

Ceritinib Package Insert Ceritinib Fda Approval Alectinib Vs Ceritinib

prevHigh quality Ready stock Osimertinib Cas 1421373-65-0 and AZD-9291

nextHigh Purity Delamanid CAS 681492-22-8 OPC-67683

High purity LDK378 Ceritinib 1032900-25-6

Contact Information